Karen S.

About Antares Antares Pharma is a specialty pharmaceutical company that combines drug development expertise with proprietary delivery technology to deliver safe and effective medicines. With a goal of improving dosing, reducing side effects, and improving patient compliance and outcomes, our pursuit of innovative therapies strives to positively affects patients’ lives. We focus on self-injection, pharmaceutical products and technologies with emphasis in rheumatology, urology, endocrinology, and neurology. Through innovation, Antares Pharma combines pharmaceutical and medical device knowledge to produce treatment options that best serve our patients, physicians, partners, and stakeholders. Our Mission We at Antares Pharma leverage our pharmaceutical and medical device expertise to develop innovative products that address needs in underserved therapeutic areas. Our relentless pursuit of better therapies that positively affect patient lives inspires our employees to serve our customers and stakeholders every day.

Forward Pharma A/S was a Danish biopharmaceutical company that from 2005 to 2017 developed a proprietary formulation of DMF for the treatment of inflammatory and neurological indications. The Company granted to Biogen an irrevocable license to all of its IP through the License Agreement and received from Biogen a non-refundable cash fee of $1.25 billion in February 2017, with the return of EUR 917.7 million to shareholders through a capital reduction in September 2017. The company completed a voluntary solvent liquidation in 2025.

Boomerang Biopathways is a full service, enterprise solution for clinical trial execution in Australia. Boomerang Biopathways Pty Ltd’s seasoned team leverage their deep global expertise to partner with companies who wish to cost effectively accelerate clinical development. Whether it is biomedical devices, pharmaceuticals or DTC, we are experienced, curious and well networked to help you with your endeavours. From legal setup to full trial execution, we offer comprehensive support, enabling companies to bring innovative therapies to market faster while enhancing value creation. With a team of seasoned experts focused on seamless trial management, Boomerang Biopathways is the trusted partner for global companies seeking to optimize their clinical development programs in Australia. For more information: https://www.linkedin.com/company/boomerang-biopathways-pty-ltd/

About Antares Antares Pharma is a specialty pharmaceutical company that combines drug development expertise with proprietary delivery technology to deliver safe and effective medicines. With a goal of improving dosing, reducing side effects, and improving patient compliance and outcomes, our pursuit of innovative therapies strives to positively affects patients’ lives. We focus on self-injection, pharmaceutical products and technologies with emphasis in rheumatology, urology, endocrinology, and neurology. Through innovation, Antares Pharma combines pharmaceutical and medical device knowledge to produce treatment options that best serve our patients, physicians, partners, and stakeholders. Our Mission We at Antares Pharma leverage our pharmaceutical and medical device expertise to develop innovative products that address needs in underserved therapeutic areas. Our relentless pursuit of better therapies that positively affect patient lives inspires our employees to serve our customers and stakeholders every day.

For Sangamo Therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. Our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. Currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. To learn more about Sangamo, visit the our website at www.sangamo.com.

Various board memberships

Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com